Reduction of N-Glycolylneuraminic Acid in Human Induced Pluripotent Stem Cells Generated or Cultured under Feeder- and Serum-Free Defined Conditions by Hayashi, Yohei et al.
Reduction of N-Glycolylneuraminic Acid in Human
Induced Pluripotent Stem Cells Generated or Cultured
under Feeder- and Serum-Free Defined Conditions
Yohei Hayashi
1., Techuan Chan
1., Masaki Warashina
2, Masakazu Fukuda
3, Takashi Ariizumi
1,K o j i
Okabayashi
1, Naoya Takayama
4, Makoto Otsu
4, Koji Eto
4, Miho Kusuda Furue
5, Tatsuo Michiue
1, Kiyoshi
Ohnuma
1,6*, Hiromitsu Nakauchi
4, Makoto Asashima
1,7*
1Department of Life Sciences (Biology), Graduate School of Arts and Sciences, The University of Tokyo, Tokyo, Japan, 2Genome Research Laboratories, Wako Pure
Chemical Industries, Ltd., Hyogo, Japan, 3Department of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo, Japan, 4Division of Stem Cell
Therapy, Center for Stem Cell and Regenerative Medicine, Institute of Medical Science, The University of Tokyo, Tokyo, Japan, 5Laboratory of Cell Cultures, Department of
Disease Bioresources, National Institute of Biomedical Innovation, Osaka, Japan, 6Top Runner Incubation Center for Academia-Industry Fusion, Nagaoka University of
Technology, Nagaoka, Japan, 7Organ Development Research Laboratory, National Institute of Advanced Industrial Science and Technology (AIST), Ibaraki, Japan
Abstract
Background: The successful establishment of human induced pluripotent stem cells (hiPSCs) has increased the possible
applications of stem cell research in biology and medicine. In particular, hiPSCs are a promising source of cells for
regenerative medicine and pharmacology. However, one of the major obstacles to such uses for hiPSCs is the risk of
contamination from undefined pathogens in conventional culture conditions that use serum replacement and mouse
embryonic fibroblasts as feeder cells.
Methodology/Principal Findings: Here we report a simple method for generating or culturing hiPSCs under feeder- and
serum-free defined culture conditions that we developed previously for human embryonic stem cells. The defined culture
condition comprises a basal medium with a minimal number of defined components including five highly purified proteins
and fibronectin as a substrate. First, hiPSCs, which were generated using Yamanaka’s four factors and conventional
undefined culture conditions, adapted to the defined culture conditions. These adapted cells retained the property of self
renewal as evaluated morphologically, the expression of self-renewal marker proteins, standard growth rates, and
pluripotency as evaluated by differentiation into derivatives of all three primary germ layers in vitro and in vivo (teratoma
formation in immunodeficient mice). Moreover, levels of nonhuman N-glycolylneuraminic acid (Neu5Gc), which is a
xenoantigenic indicator of pathogen contamination in human iPS cell cultures, were markedly decreased in hiPSCs cultured
under the defined conditions. Second, we successfully generated hiPSCs using adult dermal fibroblast under the defined
culture conditions from the reprogramming step. For a long therm culture, the generated cells also had the property of self
renewal and pluripotency, they carried a normal karyotype, and they were Neu5Gc negative.
Conclusion/Significance: This study suggested that generation or adaption culturing under defined culture conditions can
eliminate the risk posed by undefined pathogens. This success in generating hiPSCs using adult fibroblast would be
beneficial for clinical application.
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Introduction
Human induced pluripotent cells (hiPSCs) generated by the
introduction of defined factors from somatic cells exhibit
pluripotency similar to human embryonic stem cells (hESCs)
[1,2]. The broad developmental potential of hiPSCs makes them a
possible source of cells for the regenerative medical transplantation
of various tissues. However, before hiPSC-derived cells can be
used in human transplantation, a number of safety concerns need
to be overcome. One such concern is the risk of contamination by
undefined pathogens or immunoreactive materials from undefined
components used in the culturing of hiPSCs [3]. N-Glycolylneur-
PLoS ONE | www.plosone.org 1 November 2010 | Volume 5 | Issue 11 | e14099aminic acid (Neu5Gc) has been identified as an immunoreactive
material that contaminates cells in culture. Neu5Gc, a sialic acid
found on the cell surface, is considered a xenoantigen for humans
because human cells cannot produce Neu5Gc genetically [4],
although it can be taken up from the culture environment [5,6].
Furthermore, most humans have circulating antibodies specific for
Neu5Gc. Contamination of hESCs by Neu5Gc was confirmed
following culturing under conventional conditions with mouse
embryonic fibroblast (MEF)-derived feeder cells and knockout
serum replacement (KSR)-supplemented medium [7,8]. Neu5Gc
could therefore be a useful indicator of pathogen contamination in
pluripotent stem cell cultures.
Defined culture conditions are therefore required when using
hiPSC to avoid contamination from undefined pathogens or
immunoreactive materials [7]. KSR-supplemented medium is not
defined and thus may contain a variety of contaminating factors
[9,10,11]. Based on previous findings indicating that the
phenotypes of hiPSCs are similar to those of hESCs [1,2], we
hypothesized that hESC culture conditions could also be used for
hiPSCs. Previously, we developed a defined serum-free medium,
namely hESF9, for culturing hESCs on a type I collagen substrate
without feeders [12]. Although several defined culture conditions
without feeders for hESCs have been reported, difficulties remain
in propagating the undifferentiated hESCs [13,14,15,16]. Recent-
ly, we found that adding activin A to hESF9 medium supports
robust propagation of hES cells and enhances the stable
attachment of these cells to fibronectin [16]. We modified our
medium accordingly and subsequently cultured our hESCs on a
fibronectin substrate without feeders. The modified medium
(hESF9a) comprises a basal medium supplemented with heparin
sulphate and five highly purified proteins: bovine pancreatic
insulin, human apotransferrin, fatty acid-free bovine serum
albumin conjugated with oleic acid, human recombinant fibroblast
growth factor (FGF)-2, and human recombinant activin [16].
In the present study, we generated hiPSCs from skin
keratinocytes using conventional culture conditions with KSR
and feeder cells [17]. The cells were then moved into defined
culture conditions in hESF9a medium on fibronectin without
feeders. We confirmed that the hiPSCs cultured under defined
conditions were pluripotent stem cells on the basis of cell
morphology, growth rate, the expression of self-renewal genes,
cell differentiation in vitro, and teratoma formation in vivo.
Furthermore, we observed that levels of Neu5Gc decreased
steadily in hiPSCs cultured under defined conditions. Finally, we
generated hiPSCs from adult dermal fibroblast under defined
conditions. For long-term culture, these hiPSCs maintained their
pluripotency and normal karyotype.
Results and Discussion
Generation of the hiPSC line and adaptation to defined
culture conditions
The hiPSC cell line was established from neonatal skin
keratinocytes by the infection of amphotropic retroviruses carrying
the OCT4, SOX2, KLF4, and C-MYC genes using conventional
culture conditions with KSR medium and mitomycin C-treated
MEF feeder cells (KSR-based conditions) [1,17,18]. Under the
KSR-based conditions, cells maintained their undifferentiated
morphology and expressed markers of pluripotency, namely ALP
(Figure 1B), NANOG (Figure 1E), OCT3/4 (Figure 1H), SSEA4
(Figure 1N), and TRA1-60 (Figure 1Q), shown by immunocyto-
chemistry or substrate staining for ALP. However, the cells did not
express stage-specific embryonic antigen (SSEA)-1, which is a self-
renewal marker of murine ES cells and a differentiation marker of
hESCs (Figure 1K). The cell line was designated UTA1.
At passage 18, the UTA1 cells were transferred into the defined
culture conditions with hESF9a medium on fibronectin-coated
dishes without feeder cells (hESF9a-based conditions) [12,16]. After
a further five passages, the UTA1 cells also expressed the self-
renewal markers, ALP (Figure 1C), NANOG (Figure 1F), OCT3/4
(Figure1I),SSEA4(Figure1O),andTRA1-60 (Figure1R);however,
there was no detectable expression of SSEA1 under either culture
condition (Figure 1L), suggesting that hiPSCs grown in the hESF9a-
based conditions maintained their undifferentiated characteristics.
The UTA1 cells steadily proliferated under hESF9a-based condi-
tions for a prolonged culture period, as in the conventional KSR-
based conditions (Figure S1). We continued to culture the UTA1
cells in hESF9a-based condition up to 27 passages. These results
suggested that the UTA1 cells cultured under the hESF9a-based
conditions retained the property of self-renewal.
In vitro and in vivo differentiation of hiPSCs under
defined culture conditions
Differentiation potential in the UTA1 cells grown under KSR-
and hESF9a-based conditions was assessed using in vitro differen-
tiation assays involving embryoid body generation. After 24 days
in differentiation culture conditions, the embryoid bodies con-
tained various types of differentiated cells characterized by germ-
layer markers as follows: MAP2 (Figure 2A, B) and TUJ1
(Figure 2C, D) as ectoderm markers; FLK1 (Figure 2E, F) and
vimentin (Figure 2G, H) as mesoderm markers; and PDX1 as an
endoderm marker (Figure 2I, J). We also validated the pluripo-
tency of UTA1 cells under KSR-based conditions (17 passages)
and hESF9a-based conditions (18 passage in KSR-based condition
and 12 passage in ESF9a-based condition) by teratoma formation
in the testes of severe combined immunodeficient (SCID) mice
injected with hiPSCs. Eight weeks after injection, histological
analysis demonstrated that the formed teratomas were derived
from all three primary germ layers. Neural tissues (ectoderm),
muscle (mesoderm), cartilage (mesoderm), and intestinal epithelia
(endoderm) were all identified histologically in the hiPSC-derived
teratomas (Figure 3). These results suggested that UTA1 cells
remained pluripotent to differentiate into all three germ layers
when grown under hESF9a-based conditions.
The level of xenoantigen Neu5Gc in the hiPSC under
defined culture conditions
Our data showed that hESF9a culture conditions maintain the
pluripotency of hiPSCs. Conventional culture conditions currently
use KSR for human ES/iPS cells, and it is accepted that these
commercially supplied components may contain undefined
animal-derived xenoantigens and pathogens. Because human cells
cannot produce Neu5Gc genetically [4], it becomes a useful
indicator of xenogenic contamination in human pluripotent stem
cells [7]. We therefore examined the expression of Neu5Gc in
UTA1 cells grown under KSR- and hESF9a-based conditions by
flow cytometry using an antibody against Neu5Gc. The level of
Neu5Gc was high in UTA1 cells cultured under the KSR-based
conditions (23 passages) and was comparable with that in Chinese
hamster ovary (CHO) cells cultured in fetal calf serum (FCS)-
containing medium (Figure 4A, B). The Neu5Gc expression
decreased almost to negative control levels (with control antibody
or no primary antibody) in UTA1 cells cultured under the
hESF9a-based conditions (18 passages in KSR-based condition
and 27 passages in ESF9a-based condition) (Figure 4C). The
conventional culture conditions contain animal-derived compo-
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PLoS ONE | www.plosone.org 2 November 2010 | Volume 5 | Issue 11 | e14099Figure 1. Self-renewal marker expression of pluripotent stem cells in hiPSCs adapted in defined culture conditions. Parental human
neonatal keratinocytes (A, D, G, J, M, and P), hiPSC line, UTA1, grown under KSR-based conditions (B, E, H, K, N, and Q), and UTA1 grown under
hESF9a-based culture conditions for 5 passages (C, F, I, L, O, and R) were fixed and reacted with antibodies (or stained with alkaline phosphatase
substrate, Fast Red). (A–C): Alkaline phosphatase staining. (D–F): Immunocytochemistry of NANOG protein. (G–I): Immunocytochemistry of OCT3/4
protein. (J–L): Immunocytochemistry of SSEA1 antigen. (M–O): Immunocytochemistry of SSEA4 antigen. (P–R): Immunocytochemistry of TRA1-60
antigen. Binding of these antibodies was visualized with AlexaFluor 488-conjugated secondary antibodies (green). Nuclei were stained with DAPI
(blue). Scale bars represent 50 mm.
doi:10.1371/journal.pone.0014099.g001
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PLoS ONE | www.plosone.org 3 November 2010 | Volume 5 | Issue 11 | e14099Figure 2. In vitro differentiation using embryoid bodies from hiPSCs adapted in defined culture conditions. Immunocytochemistry of
MAP2 (A, B), TUJ (C, D), FLK1 (E, F), vimentin (G, H), and PDX1 (I, J) in the differentiated hiPSC line, UTA1, grown under KSR-based conditions (A, C, E, G,
I) or hESF9a-based conditions (B, D, F, H, J). Differentiation was performed using embryoid body formation, and the differentiated cells were fixed and
reacted with antibodies. Binding of these antibodies was visualized with AlexaFluor 488-conjugated secondary antibodies (green). Nuclei were
stained with DAPI (blue). Scale bars represent 50 mm.
doi:10.1371/journal.pone.0014099.g002
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porcine gelatin. Further, the KSR used for the conventional
culture conditions also includes animal-derived components, such
as lipid-enriched bovine serum albumin [9,10,11]. Hence, the
UTA1 cells might metabolically incorporate substantial amounts
of Neu5Gc from these factors. However, although the hESF9a-
based conditions also contain animal-derived components such as
bovine insulin, bovine serum albumin, porcine heparin, and
bovine fibronectin, the UTA1 cells incorporate only low amounts
of Neu5Gc. These results suggested that culturing of hiPSCs under
the defined conditions with purified components could decrease
the risk of xenogenic and human-derived pathogens.
The generation of hiPSC lines using adult dermal
fibroblasts under feeder- and serum-free, defined culture
conditions from the reprogramming step
Next, we examined whether hiPSCs were generated from the
reprogramming step under our feeder-free, defined culture
conditions. For comparison, we used another defined xeno-free
Figure3.Theinvivodifferentiation usingteratomaformationofhiPSCsadapted indefinedcultureconditions. Teratomawere generated
in SCID mice from UTA1 grown under KSR-based and hESF9a-based conditions. Histological analysis with HE staining demonstrated that teratoma
formed by the UTA1 cells cultured in both KSR-based (A, C, E, G) and hESF9a-based conditions (B, D, F, H) contained derivatives of all three germ layers.
Histology of teratoma derived from UTA1 cultured under KSR-based (A) or hESF9a-based conditions (B). Neural tissues in teratoma derived from UTA1
cultured under KSR-based (C) or hESF9a-based conditions (D). (E): Muscle. (F): Cartilage. (G and H): Intestinal epithelia. Scale bars represent 100 mm.
doi:10.1371/journal.pone.0014099.g003
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for culturing human pluripotent stem cells. Adult human dermal
fibroblasts (HDF) were infected with amphotropic retroviruses
carrying the OCT4, SOX2, KLF4, and C-MYC genes and were
cultured under hESF9a-based conditions or under TeSR2-based
conditions (with TeSR2 medium on matrigel-coated dishes). After
26 days of culture, we detected hiPSC-like colonies by staining for
ALP substrate or by their morphologies (Figure 5A). While no
hiPSC-like colonies were detected under the TeSR2-based
conditions, eight hiPSC-like colonies were detected under the
hESF9a-based condition. We confirmed these results by indepen-
dent multiple experiments (0 ALP-positive colonies/2 experiments
in TeSR2-based conditions and 3 ALP-positive colonies/2
experiments in hESF9a-based conditions) (Figure 5B and C). In
another experiment of the hiPSCs induction under hESF9a-based
conditions, we picked up hiPS-like colonies for expansion under
the same culture conditions. The ALP activity was maintained at 5
passages (Figure 5D). After 25–26 passages, we confirmed self-
renewal marker expression and differentiation potential in these
cell lines by immunocytochemistry (Figure 6, 7). One of the cell
lines, designated UTA-SF2-2, retained proper proliferation rates
for human pluripotent stem cells (Figure 8A; population doubling
time: 28.264.9 h). Karyotype analysis revealed that UTA-SF2-2
cells at passage 31 was 46XX (Figure 8B). Finally, we examined
Neu5Gc expression in the UTASF2-2 line by flow cytometry and
showed that the levels of Neu5Gc in passage-30 cells were almost
negative, as in negative control cells (Figure 9). Our established cell
lines therefore showed little or no Neu5Gc contamination,
suggesting that the hESF9a-based culture conditions generated
hiPSCs steadily from reprogramming step using adult HDF and
supported their pluripotency for long-term culture with less
contamination of pathogens.
Recently, the generation of induced pluripotent stem cells under
xeno-free culture conditions has been reported [19,20]. These
culture conditions contain human plasma or xeno-free KSR on
irradiated human fibroblasts. However, the components of KSR
or xeno-free KSR are not publicly available. For clinical
application, all the components used should be traceable and also
widely reviewed. Our defined culture methods without feeder cells
make it easier to track all the components because the minimum
essential components, only five highly purified proteins with
heparin, are added into the basal medium. Previously, human
iPSCs were also generated using a defined medium, mTeSR1
from not adult but neonatal HDF (ADA) [21] or adult adipose
stem cells [22]. Sun et al. also reported that no iPS-like colonies
were generated from neonatal HDF (IMR90) using mTeSR1
medium [22]. Together with our results that hiPSCs from adult
HDF were derived under defined culture conditions for the first
time and steadily, our hESF9a medium is suitable to generate
hiPSCs from adult HDF. Compared with our hESF9a medium,
mTeSR1 and TeSR2 medium contain a variety of chemicals
(inorganic chemicals, trace minerals, lipids, surfactants, and amino
acid derivatives) that regulate signal transduction and metabolism
[13]. Although these chemicals may enhance the self-renewal of
human pluripotent stem cells, some may inhibit the reprogram-
ming steps during human iPSC generation.
Conclusions
This study demonstrated that defined culture conditions that
were developed for hESCs are also applicable for hiPSCs. The
hiPSCs were generated under conventional KSR-based conditions
and then adapted to the defined hESF9a-based condition.
Moreover, we succeeded to generate the hiPSCs from adult
HDF under hESF9a-based conditions. The levels of xenoantigen
Neu5Gc were markedly decreased in the hiPSCs which were
either adapted or generated in the hESF9a-based condition. The
hESF9a media consists of a basal medium and known compo-
nents, reducing the risk of contamination from undefined
pathogens and antigens. Taken together, our findings suggested
that the defined culture conditions described herein are suitable
for culturing hiPSCs with the added benefit of eliminating
contamination risks caused by undefined factors. The defined
Figure 4. Decreased expression of xenoantigen Neu5Gc in
hiPSCs adapted under defined culture conditions. Flow cytom-
etry analysis of Neu5Gc expression. CHO cells were grown in FCS-
containing medium (A) and hiPSCs were grown under KSR-based
conditions (B) or hESF9a-based conditions (C). The cells were exposed
to anti-Neu5Gc antibody (red), control antibody (green), or blocking
buffer (blue), and then stained with a secondary antibody for analysis
by flow cytometry.
doi:10.1371/journal.pone.0014099.g004
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clinical applications.
Materials and Methods
hiPSCs induction and cell culture
Human neonatal keratinocytes were purchased from Invitrogen
(Carlsbad, CA). An hiPS cell line was generated using the VSV-G-
pseudotyped retroviral vector system carrying OCT4, SOX2, KLF4,
and C-MYC as described previously [18]; the line was designated
UTA1. UTA1 cells were maintained in DMEM-F12 medium
(Invitrogen) supplemented with 20% KSR (Invitrogen), 0.1 mM 2-
mercaptoethanol (Sigma, St. Louis, MO), MEM non-essential
amino acids (Invitrogen), and 5–10 ng/mL recombinant human
basic FGF (Peprotech, Rocky Hill, NJ) on mitomycin C-treated
mouse embryo fibroblast feeder cells. For subculturing, the cells
were detached from the culture dish using CTK medium [17].
The mouse embryonic fibroblasts were cultured in fibroblast
medium (DMEM medium supplemented with 10% fetal calf
serum, 1% penicillin, and 1% streptomycin) on gelatin-coated
dishes.
UTA1 cells at passage number 18 were transferred into a
defined feeder- and serum-free culture condition, the hESF9a-
based condition (with hESF9a medium and fibronectin coat), and
passaged a further 5 times at least before assaying. The hESF9a
medium comprises hESF-Grow medium (Cell Science & Tech-
nology Institute, Miyagi, Japan) supplemented with 10 mg/mL of
bovine pancreas insulin (Sigma I-5500), 5 mg/mL human
apotransferrin (Sigma T-1147), 10 mM 2-mercaptoethanol (Sigma
M-7522), 10 mM ethanolamine (Sigma E-0135), 20 nM sodium
selenite (Sigma S-9133), 4.7 mg/mL of oleic acid conjugated with
0.5 mg/mL of fraction V fatty acid-free bovine serum albumin
(Sigma O-3008), 100 ng/mL L-ascorbic acid-2-phosphate (Wako,
Osaka, Japan, 013-196411), 100 ng/mL heparin sodium salt from
porcine intestinal mucosa (Sigma H-3149), 10 ng/mL human
recombinant fibroblast growth factor 2 (FGF-2, Peprotech 100-
18B), and 10 ng/mL human recombinant activin A (Ajinomoto
Pharmaceuticals, Japan) [12,16]. The culture dishes were coated
with 2 mg/cm
2 fibronectin from bovine plasma (Sigma F-1141) in
PBS for at least 30 min at 37uC, and then excess solution was
removed. For subculturing, the cells were detached from the
culture dish using 50,300 mg/mL dispase (Invitrogen 17105-041)
in hESF9a medium and replated in hESF9a medium with 5 mM
ROCK inhibitor (Y-27632; Wako Pure Chemical Industries, Ltd.,
Japan). Medium changes were made every day with hESF9a
medium.
Chinese hamster ovary (CHO) cells (No. 85050302, European
Collection of Cell Culture) were maintained in DMEM-F12
(Invitrogen) supplemented with 10% fetal calf serum, 1%
penicillin, and 1% streptomycin.
Generation and maintenance of hiPSCs in feeder- and
serum-free defined culture condition from
reprogramming step
Four hiPSC lines, UTA-SF2-1, UTA-SF2-2, UTA-SF3-1, and
UTA-SF3-2, were generated from primary adult human dermal
fibroblasts (female of 41, 46, or 51 yr old; 106-05a, cell
applications, inc. San Diego, CA) under hESF9a-based conditions.
The HDFs were seeded at 8610
5 cells/dish in 10-cm petri dishes
coated with gelatin in the fibroblast medium. The VSV-G-
pseudotyped retroviral vector system carrying OCT4, SOX2,
KLF4, and C-MYC was added to HDF cultures. After two 24-
hour-exposures of virus, the transduced HDFs were replated at
6610
4 cells/dish onto 10-cm petri dishes coated with fibronectin
or matrigel in the fibroblast medium. On the next day, the
medium was changed to hESF9a (on fibronectin-coated dishes) or
TeSR2 (on matrigel-coated dishes), and thereafter changed daily.
Figure 5. Generation of hiPSC lines under defined culture conditions. (A):ALP staining of HDFs cultured in hESF9a (left) and in TeSR2 (right)
at 26 days after virus transduction. Red arrows indicate the ALP-positive hiPSC-like colonies. (B and C): The appearances of transduced HDFs cultured
in TeSR2 (B) and in hESF9a (C). Cells were fixed and stained with ALP substrate BM purple at 26 days after virus transduction. (D): ALP staining of the
hiPSC-like colony picked up and cultured under hESF9a conditions at five passages. Scale bars represent 50 mm.
doi:10.1371/journal.pone.0014099.g005
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PLoS ONE | www.plosone.org 7 November 2010 | Volume 5 | Issue 11 | e14099Figure 6. Self-renewal marker expression of pluripotent stem cells in hiPSCs generated and maintained in defined culture
conditions. Parental human dermal fibroblasts (A, C, E, G, I, and K), and hiPSC line, SF2-2 generated and maintained under the ESF9-based
conditions (B, D, F, H, J, and L) were fixed and reacted with antibodies (or stained with alkaline phosphatase substrate, BM Purple). (A and B): Alkaline
phosphatase staining. (C and D): Immunocytochemistry of NANOG protein. (E and F): Immunocytochemistry of OCT3/4 protein. (G and H):
Immunocytochemistry of SSEA1 antigen. (I and J): Immunocytochemistry of SSEA4 antigen. (K and L): Immunocytochemistry of TRA1-60 antigen.
Binding of these antibodies was visualized with Alexafluor 488-conjugated secondary antibodies (green). Nuclei were stained with DAPI (blue). Scale
bars are 50 mm.
doi:10.1371/journal.pone.0014099.g006
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picked up and cultured in the same defined culture conditions as
described for the hiPSC UTA1 cell lines.
Alkaline phosphatase (ALP) staining
Cells were fixed with 4% paraformaldehyde (PFA) in phos-
phate-buffered saline (PBS) at room temperature for 10 minutes.
The fixed cells were washed with PBS three times and then twice
with alkaline phosphatase (ALP) buffer. Finally, these samples
were stained with ALP substrate Fast-Red (Nichirei, Japan) or BM
purple (Roche, Switzerland) for 30 minutes at room temperature.
Embryoid body formation
In vitro differentiation was induced by the formation of embryoid
bodies as described previously [12]. Briefly, undifferentiated
Figure 7. In vitro differentiation using embryoid bodies from
hiPSCs generated and maintained in defined culture condi-
tions. Immunohistochemistry of MAP2 (A), TUJ (B), FLK1 (C), VIMENTIN
(D), and PDX1 (E) in the differentiated hiPSC line, UTA-SF-2-2, grown
under hESF9a-based conditions. Differentiation was performed using
embryoid body formation. The tissues in embryoid bodies were fixed
and reacted with antibodies. Binding of these antibodies was visualized
with AlexaFluor 488-conjugated secondary antibodies (green). Nuclei
were stained with DAPI (blue). Scale bars are 50 mm.
doi:10.1371/journal.pone.0014099.g007
Figure 8. Cell growth and karyotype of hiPSCs generated and
maintained in defined culture conditions. (A): Growth curves for
the hiPSC line. UTA-SF2-2 hiPSCs cultured under hESF9a-based
conditions at passages 29, 30, and 31 were seeded in a 6-well plate
coated with fibronectin and counted every 48 h. The values are the
mean 6 SEM (n=3). (B): Representative G-banded karyotype of
chromosome in a UTASF2-2 hiPSC at passage 31 maintained under
hESF91-based conditions.
doi:10.1371/journal.pone.0014099.g008
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attachment plates (Corning, Corning, NY). Then, floating
embryoid bodies were replated onto gelatin-coated dishes in the
same culture medium for 16 days.
Immunocytochemistry
Immunocytochemistry was performed as described previously
[23,24,25]. Briefly, hiPSCs were fixed in 4% PFA, permeabilized
with 0.1% Triton X-100, blocked with 1% BSA, and then reacted
with primary antibodies. The primary antibody binding was
visualized with AlexaFluor 488-conjugated anti-rabbit, anti-
mouse, and anti-goat IgG or AlexaFluor 594-conjugated donkey
anti-mouse, anti-rabbit, or anti-goat IgG (Invitrogen). The
following primary antibodies were used: anti-FLK1 antibody
(Chemicon, Billerica, MA; 1:100), anti-MAP2 antibody (Chemi-
con; 1:200), anti-PDX1 antibody (Chemicon; 1:100), anti-
NANOG antibody (Reprocell, Tokyo, Japan; 1:200), anti-
OCT3/4 antibody (Santa Cruz Biotechnology, Santa Cruz, CA
1:100), anti-SSEA1 antibody (Kyowa, Tokyo, Japan; 1:100), anti-
SSEA4 antibody (eBiosciences, San Diego, CA; 1:100), anti-TUJ
antibody (Chemicon; 1:100), and anti-vimentin antibody (Santa
Cruz Biotechnology; 1:200).
Teratoma formation assay
For teratoma formation assays, approximately 3 million hiPSCs
were suspended in 60 mL of PBS and injected into the testes of
anesthetized severe combined immunodeficient (SCID) mice. The
tumors were excised 8 weeks after injection, fixed in 4% PFA,
embedded in paraffin, and then sectioned at 8 mm. The histology
of formed teratomas was analyzed using hematoxylin-eosin (HE)
staining. The Institutional Animal Care and Use Committee of the
Institute of Medical Science, University of Tokyo approved the use
of experimental animals (the permit number was PA09-4).
Flow cytometry
Flow cytometry for Neu5Gc was performed as described
previously [7]. Briefly, all cells were removed from culture dishes
using 0.02% (w/v) EDTA-4Na in PBS. The hiPSCs cultured
under KSR-based conditions were then replated on plastic dishes
and incubated for 1 hour to remove the MEFs, and then 0.5–
2.5610
6 cells were incubated with a chicken anti-Neu5Gc (Gc-
Free, 1:100 dilution) antibody or a control antibody (Gc-Free,
1:100 dilution) in PBS containing blocking buffer (Gc-Free), but
without Neu5Gc. The cells were finally incubated with a donkey
anti-chicken IgY secondary antibody conjugated to Cy5 (Jackson;
diluted 1:500 in PBS containing blocking buffer). A FACS-Calibur
(BD) was used for data acquisition.
Supporting Information
Figure S1 Cell growth of hiPSCs cultured under defined culture
conditions. Growth curves for the hiPSC line, UTA1, cultured
under KSR-based or hESF9a-based conditions. Growth curves
were calculated from each passage split ratio. The relative cell
number was set as 1 when the hiPSCs were cultured at passage 18
for conventional feeder conditions or at passage 5 for defined
culture conditions.
Found at: doi:10.1371/journal.pone.0014099.s001 (2.10 MB TIF)
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